Inventor
GARIN-CHESA PILAR
DE24 patents
⚠️ This page may combine multiple inventors who share the name “GARIN-CHESA PILAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SLOAN KETTERING INST CANCER
10 patentsUS6310185B1Oct 30, 2001
Recombinant human anti-Lewis Y antibodies
SLOAN KETTERING INST CANCER112 citations97
US5874060AFeb 23, 1999
Recombinant human anti-Lewis Y antibodies
SLOAN KETTERING INST CANCER49 citations95
US5646253AJul 8, 1997
Recombinant human anti-LK26 antibodies
SLOAN KETTERING INST CANCER58 citations95
US6348195B1Feb 19, 2002
Method for treating cancers
SLOAN KETTERING INST CANCER25 citations92
US5587299ADec 24, 1996
Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof
SLOAN KETTERING INST CANCER30 citations92
US5437865AAug 1, 1995
Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium
SLOAN KETTERING INST CANCER12 citations74
US5059523AOct 22, 1991
Cell-surface glycoproteins of human sarcomas
SLOAN KETTERING INST CANCER8 citations72
US5536641AJul 16, 1996
Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells
SLOAN KETTERING INST CANCER10 citations71
US5618534AApr 8, 1997
Isolated antigen endo glyx-1
SLOAN KETTERING INST CANCER0 citations50
US5565356AOct 15, 1996
Hybridoma cell lines which produce monoclonal antibodies having the properties of monoclonal antibody 100-310 and the monoclonal antibodies produced by these hybridoma cell lines
SLOAN KETTERING INST CANCER1 citations47
LUDWIG INST CANCER RES
9 patentsUS5342757AAug 30, 1994
Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
LUDWIG INST CANCER RES69 citations96
US6391302B1May 21, 2002
Method for treating cancers which present antigen FB5 with humanized antibodies
LUDWIG INST CANCER RES18 citations92
US6217868B1Apr 17, 2001
Methods for detecting cancer cells by using humanized antibodies which bind specifically to FB5 antigen
LUDWIG INST CANCER RES19 citations92
US6124106ASep 26, 2000
Method for detecting cancers
LUDWIG INST CANCER RES29 citations92
US6090930AJul 18, 2000
Recombinant human anti-FB5 antibodies
LUDWIG INST CANCER RES25 citations92
US5843448ADec 1, 1998
Tumor rejection antigen precursor
LUDWIG INST CANCER RES22 citations92
US5811522ASep 22, 1998
Recombinant humanized anti-FB5 antibodies
LUDWIG INST CANCER RES20 citations92
US6518415B1Feb 11, 2003
Recombinant human anti-Lewis Y antibodies
LUDWIG INST CANCER RES11 citations73
US5541104AJul 30, 1996
Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1
LUDWIG INST CANCER RES8 citations73